240 related articles for article (PubMed ID: 33081494)
1. Vascular endothelial growth factor (VEGF)-A and VEGF-A
Kikuchi R; Tsuboi N; Sada KE; Nakatochi M; Yokoe Y; Suzuki A; Maruyama S; Murohara T; Matsushita T; ; Amano K; Atsumi T; Takasaki Y; Ito S; Hasegawa H; Dobashi H; Ito T; Makino H; Matsuo S
Ann Clin Biochem; 2021 Mar; 58(2):86-94. PubMed ID: 33081494
[TBL] [Abstract][Full Text] [Related]
2. ANCA-Associated Vasculitis: Core Curriculum 2020.
Geetha D; Jefferson JA
Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
[TBL] [Abstract][Full Text] [Related]
3. Serum Mannose-Binding Lectin Levels Are Correlated with the Disease Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single-Center Study.
Yoon T; Ahn SS; Yoo J; Yoo BW; Kwon HC; Jung SM; Song JJ; Park YB; Lee SW
Tohoku J Exp Med; 2020 Jun; 251(2):117-123. PubMed ID: 32581191
[TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
5. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
6. Complement profile in microscopic polyangiitis and granulomatosis with polyangiitis: analysis using sera from a nationwide prospective cohort study.
Fukui S; Ichinose K; Sada KE; Miyamoto J; Harigai M; Amano K; Atsumi T; Takasaki Y; Dobashi H; Arimura Y; Hasegawa H; Yuzawa Y; Yamagata K; Tsuboi N; Maruyama S; Matsuo S; Makino H; Maeda T; Kawakami A
Scand J Rheumatol; 2020 Jul; 49(4):301-311. PubMed ID: 32286129
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of tissue inhibitor of metalloproteinase 1 as a predictor of sustained remission in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Ishizaki J; Takemori A; Horie K; Hiraoka D; Suemori K; Matsumoto T; Sada KE; Amano K; Harigai M; Arimura Y; Makino H; Takenaka K; Takemori N; Hasegawa H;
Arthritis Res Ther; 2021 Mar; 23(1):91. PubMed ID: 33743769
[TBL] [Abstract][Full Text] [Related]
9. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
[TBL] [Abstract][Full Text] [Related]
10. Novel Therapies for ANCA-associated Vasculitis.
Monti S; Brandolino F; Milanesi A; Xoxi B; Delvino P; Montecucco C
Curr Rheumatol Rep; 2021 Apr; 23(6):38. PubMed ID: 33909172
[TBL] [Abstract][Full Text] [Related]
11. Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis.
Ishizaki J; Takemori A; Suemori K; Matsumoto T; Akita Y; Sada KE; Yuzawa Y; Amano K; Takasaki Y; Harigai M; Arimura Y; Makino H; Yasukawa M; Takemori N; Hasegawa H;
Arthritis Res Ther; 2017 Sep; 19(1):218. PubMed ID: 28962592
[TBL] [Abstract][Full Text] [Related]
12. Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations.
Casal Moura M; Gauckler P; Anders HJ; Bruchfeld A; Fernandez-Juarez GM; Floege J; Frangou E; Goumenos D; Segelmark M; Turkmen K; van Kooten C; Tesar V; Geetha D; Fervenza FC; Jayne DRW; Stevens KI; Kronbichler A
Nephrol Dial Transplant; 2023 Oct; 38(11):2637-2651. PubMed ID: 37164940
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Beketova TV
Ter Arkh; 2018 May; 90(5):13-22. PubMed ID: 30701885
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis.
Yamada Y; Harada M; Hara Y; Iwabuchi R; Hashimoto K; Yamamoto S; Kamijo Y
Arthritis Res Ther; 2021 Jan; 23(1):28. PubMed ID: 33446268
[TBL] [Abstract][Full Text] [Related]
16. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
17. Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis.
Hashimoto T; Ueki S; Kamide Y; Miyabe Y; Fukuchi M; Yokoyama Y; Furukawa T; Azuma N; Oka N; Takeuchi H; Kanno K; Ishida-Yamamoto A; Taniguchi M; Hashiramoto A; Matsui K
Front Immunol; 2021; 12():801897. PubMed ID: 35095884
[TBL] [Abstract][Full Text] [Related]
18. Monitoring disease activity in antineutrophil antibody-associated vasculitis.
Scurt FG; Hirschfeld V; Schubert L; Mertens PR; Chatzikyrkou C
Scand J Immunol; 2023 Jul; 98(1):e13284. PubMed ID: 37132459
[TBL] [Abstract][Full Text] [Related]
19. Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis.
Willeke P; Schlüter B; Sauerland C; Becker H; Reuter S; Jacobi A; Schotte H
PLoS One; 2015; 10(9):e0137196. PubMed ID: 26339905
[TBL] [Abstract][Full Text] [Related]
20. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
